Advertisement
Polyrizon Ltd. (PLRZ)
NASDAQ: PLRZ
· Real-Time Price · USD
0.31
-0.00 (-1.21%)
At close: Apr 29, 2025, 11:25 AM
Company Description
Polyrizon Ltd., a biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel.
The company's nasal sprays provide a barrier against viruses and allergens from contacting the nasal epithelial tissue.
It develops PL-14, a nasal allergies blocker; PL-15 for COVID-19; and PL-16 for influenza.
The company was incorporated in 2005 is headquartered in Ra'anana, Israel.
Polyrizon Ltd.
| Country | IL |
| IPO Date | Oct 29, 2024 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 2 |
| CEO | Tomer Izraeli |
Advertisement
Contact Details
Address: 5 Ha-Tidhar Street Ra'anana, IL | |
| Website | https://www.polyrizon-biotech.com |
Stock Details
| Ticker Symbol | PLRZ |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001893645 |
| CUSIP Number | n/a |
| ISIN Number | IL0011814113 |
| Employer ID | 00-0000000 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Tomer Izraeli | Founder, Chief Executive Officer & Director |
| Daphna Avital | Chief People Officer |
| Dr. Tidhar Turgeman | Chief Technology Officer |
| Nir Ben Yosef | Chief Financial Officer & Compliance Officer |
| Dr. Eyal S. Ron Ph.D. | Chief Scientific Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 25, 2025 | 6-K | Filing |
| Apr 17, 2025 | 6-K | Filing |
| Apr 02, 2025 | 6-K | Filing |
| Apr 01, 2025 | 6-K | Filing |
| Mar 27, 2025 | 6-K | Filing |
| Mar 25, 2025 | 6-K | Filing |
| Mar 14, 2025 | 6-K | Filing |
| Mar 13, 2025 | 6-K | Filing |
| Mar 11, 2025 | POS AM | Filing |
| Mar 11, 2025 | 20-F | Filing |